| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 电解质类药物(元) | 235,658,126.11 | 120,965,254.28 | 195,605,292.06 | 100,119,332.83 |
| 骨科药物(元) | 270,398,757.52 | 149,945,470.09 | 265,865,821.21 | 135,589,116.58 |
| 抗肝炎药物(元) | 25,242,639.57 | 12,069,993.77 | 28,280,613.73 | 15,590,216.67 |
| 抗感染药物(元) | 63,406,768.44 | 32,152,550.71 | 166,186,930.25 | 95,252,250.25 |
| 抗肿瘤药物(元) | 177,037,197.40 | 87,763,285.40 | 226,533,904.99 | 108,811,021.59 |
| 免疫增强药物(元) | - | 943,396.22 | 16,037,735.86 | 10,377,358.48 |
| 肾病用药(元) | 21,061,234.89 | 15,038,766.25 | 49,445,526.94 | 26,827,935.89 |
| 消化系统药物(元) | 34,028,684.37 | 18,395,469.42 | 36,949,415.08 | 17,899,843.30 |
| 心脑血管药物(元) | 679,825,705.33 | 360,182,739.98 | 715,296,444.61 | 348,784,747.86 |
| 血液系统药物(元) | 5,840,867.86 | 3,587,024.33 | 103,001,122.53 | 91,610,621.87 |
| 营养类药物(元) | 1,084,405,601.17 | 620,360,227.63 | 1,274,406,407.10 | 625,686,875.41 |
| 其他主营业务(元) | - | - | - | 23,019,345.72 |
| 其他(元) | 7,800,205.53 | 4,454,599.60 | 6,725,393.18 | 23,019,345.72 |
| 其他用药领域(元) | 21,333,518.52 | 6,804,422.80 | 23,610,553.06 | - |
| 营业成本(元) | ||||
| 电解质类药物(元) | 91,812,609.51 | - | 72,898,758.94 | - |
| 骨科药物(元) | 45,471,518.83 | 23,569,479.29 | 37,635,512.40 | - |
| 抗肝炎药物(元) | 7,177,887.91 | - | 6,320,308.96 | - |
| 抗感染药物(元) | 54,189,230.94 | - | 78,933,005.16 | - |
| 抗肿瘤药物(元) | 30,391,090.32 | - | 35,939,528.86 | - |
| 免疫增强药物(元) | - | - | - | - |
| 肾病用药(元) | 15,291,522.48 | - | 19,558,302.01 | - |
| 消化系统药物(元) | 8,136,732.99 | - | 16,256,561.77 | - |
| 心脑血管药物(元) | 343,697,208.06 | 152,998,804.37 | 306,301,802.00 | 148,726,730.11 |
| 血液系统药物(元) | 3,529,623.68 | - | 94,279,284.96 | - |
| 营养类药物(元) | 484,740,954.39 | 20,260,895.93 | 34,170,667.95 | 17,756,006.16 |
| 其他主营业务(元) | - | - | - | - |
| 其他(元) | 1,999,661.00 | - | 2,244,738.11 | - |
| 其他用药领域(元) | 6,273,043.27 | - | 14,675,989.52 | - |
| 毛利(元) | ||||
| 电解质类药物(元) | 143,845,516.60 | - | 122,706,533.12 | - |
| 骨科药物(元) | 224,927,238.69 | 126,375,990.80 | 228,230,308.81 | - |
| 抗肝炎药物(元) | 18,064,751.66 | - | 21,960,304.77 | - |
| 抗感染药物(元) | 9,217,537.50 | - | 87,253,925.09 | - |
| 抗肿瘤药物(元) | 146,646,107.08 | - | 190,594,376.13 | - |
| 免疫增强药物(元) | - | - | 16,037,735.86 | - |
| 肾病用药(元) | 5,769,712.41 | - | 29,887,224.93 | - |
| 消化系统药物(元) | 25,891,951.38 | - | 20,692,853.31 | - |
| 心脑血管药物(元) | 336,128,497.27 | 207,183,935.61 | 408,994,642.61 | 200,058,017.75 |
| 血液系统药物(元) | 2,311,244.18 | - | 8,721,837.57 | - |
| 营养类药物(元) | 599,664,646.78 | 600,099,331.70 | 1,240,235,739.15 | 607,930,869.25 |
| 其他主营业务(元) | - | - | - | - |
| 其他(元) | 5,800,544.53 | - | 4,480,655.07 | - |
| 其他用药领域(元) | 15,060,475.25 | - | 8,934,563.54 | - |
| 毛利率(%) | ||||
| 电解质类药物(%) | 61.04 | - | 62.73 | - |
| 骨科药物(%) | 83.18 | 84.28 | 85.84 | - |
| 抗肝炎药物(%) | 71.56 | - | 77.65 | - |
| 抗感染药物(%) | 14.54 | - | 52.50 | - |
| 抗肿瘤药物(%) | 82.83 | - | 84.14 | - |
| 免疫增强药物(%) | - | - | - | - |
| 肾病用药(%) | 27.39 | - | 60.44 | - |
| 消化系统药物(%) | 76.09 | - | 56.00 | - |
| 心脑血管药物(%) | 49.44 | 57.52 | 57.18 | 57.36 |
| 血液系统药物(%) | 39.57 | - | 8.47 | - |
| 营养类药物(%) | 55.30 | 96.73 | 97.32 | 97.16 |
| 其他主营业务(%) | - | - | - | - |
| 其他(%) | 74.36 | - | 66.62 | - |
| 其他用药领域(%) | 70.60 | - | 37.84 | - |
| 收入构成(%) | ||||
| 电解质类药物(%) | 8.97 | 8.44 | 6.29 | 6.17 |
| 骨科药物(%) | 10.30 | 10.47 | 8.55 | 8.36 |
| 抗肝炎药物(%) | 0.96 | 0.84 | 0.91 | 0.96 |
| 抗感染药物(%) | 2.41 | 2.24 | 5.35 | 5.87 |
| 抗肿瘤药物(%) | 6.74 | 6.13 | 7.29 | 6.71 |
| 免疫增强药物(%) | - | 0.07 | 0.52 | 0.64 |
| 肾病用药(%) | 0.80 | 1.05 | 1.59 | 1.65 |
| 消化系统药物(%) | 1.30 | 1.28 | 1.19 | 1.10 |
| 心脑血管药物(%) | 25.89 | 25.14 | 23.02 | 21.50 |
| 血液系统药物(%) | 0.22 | 0.25 | 3.31 | 5.65 |
| 营养类药物(%) | 41.29 | 43.30 | 41.00 | 38.56 |
| 其他主营业务(%) | - | - | - | 1.42 |
| 其他(%) | 0.30 | 0.31 | 0.22 | 1.42 |
| 其他用药领域(%) | 0.81 | 0.47 | 0.76 | - |
| 毛利构成(%) | ||||
| 电解质类药物(%) | 9.38 | 0.00 | 5.14 | 0.00 |
| 骨科药物(%) | 14.67 | 13.54 | 9.55 | 0.00 |
| 抗肝炎药物(%) | 1.18 | 0.00 | 0.92 | 0.00 |
| 抗感染药物(%) | 0.60 | 0.00 | 3.65 | 0.00 |
| 抗肿瘤药物(%) | 9.56 | 0.00 | 7.98 | 0.00 |
| 免疫增强药物(%) | - | 0.00 | 0.67 | 0.00 |
| 肾病用药(%) | 0.38 | 0.00 | 1.25 | 0.00 |
| 消化系统药物(%) | 1.69 | 0.00 | 0.87 | 0.00 |
| 心脑血管药物(%) | 21.92 | 22.19 | 17.12 | 24.76 |
| 血液系统药物(%) | 0.15 | 0.00 | 0.37 | 0.00 |
| 营养类药物(%) | 39.11 | 64.27 | 51.92 | 75.24 |
| 其他主营业务(%) | - | - | - | 0.00 |
| 其他(%) | 0.38 | 0.00 | 0.19 | 0.00 |
| 其他用药领域(%) | 0.98 | 0.00 | 0.37 | - |